Oncostatin M Receptor as a Therapeutic Target for Radioimmune Therapy in Synovial Sarcoma

Oncostatin M Receptor as a Therapeutic Target for Radioimmune Therapy in Synovial Sarcoma

Synovial sarcoma (SS) is a pediatric muscle cancer that primarily affects adolescents and young adults and has few treatment options. Complicating the treatment of synovial sarcoma is the low mutational burden of SS. Inflammatory pathways have been identified as being upregulated in some SS, leading...

Full description

Bibliographic Details
Main Authors: Sarah McCollum, Austen Kalivas, Matthew Kirkham, Kaden Kunz, Jeffrey Okojie, Adriene Pavek, Jared Barrott
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Pharmaceuticals
Subjects:
synovial sarcoma
sarcoma
oncology
radioimmune therapy
RIT
OSMR
Online Access:https://www.mdpi.com/1424-8247/15/6/650

Internet

https://www.mdpi.com/1424-8247/15/6/650

Similar Items